ZEUS System (Zio Watch) vs Cardiologs Holter Platform

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by iRhythm Technologies
VS
by Philips (Cardiologs)

AI Verdict

Tool A, the ZEUS System, is an integrated solution featuring a proprietary wearable for long-term continuous cardiac monitoring, specifically designed for detecting AFib and other arrhythmias. In contrast, Tool B, the Cardiologs Holter Platform, is a cloud-based AI platform focused on rapidly analyzing data from existing, vendor-neutral Holter devices for a broad range of arrhythmias. While both leverage AI for cardiac rhythm analysis, their distinct approaches to data acquisition and monitoring duration position them for different clinical applications.

Choose ZEUS System (Zio Watch) if…

Choose the ZEUS System (Zio Watch) if you require long-term, continuous cardiac monitoring for up to 14 days, particularly for detecting and characterizing Atrial Fibrillation (AFib) burden and other intermittent arrhythmias. This wearable solution is ideal for patients needing extended observation beyond a standard Holter, offering a patient app for symptom logging and direct data collection.

View ZEUS System (Zio Watch) →

Choose Cardiologs Holter Platform if…

Choose the Cardiologs Holter Platform if your primary need is fast, accurate, and AI-powered analysis of traditional Holter ECG recordings from various devices. This cloud-based solution streamlines cardiac diagnostics by quickly detecting over 20 types of arrhythmias and generating enriched reports, significantly reducing analysis time for existing Holter data.

View Cardiologs Holter Platform →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature ZEUS System (Zio Watch) Cardiologs Holter Platform
Pricing Contact vendor Unknown
Deployment Cloud-based system with a wearable device Cloud
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ZEUS System (Zio Watch)

Tool A offers a comprehensive, integrated user experience from patient data collection via the wearable Zio Watch and MyZio app, to physician review through the ZioSuite portal and mobile app. This end-to-end system, including patient engagement tools, provides a more holistic and user-friendly experience across the entire monitoring journey.

Clinical Value

ZEUS System (Zio Watch)

Tool A excels in clinical value through its long-term continuous monitoring capability (up to 14 days) via a wearable device, which is crucial for detecting intermittent arrhythmias like AFib that might be missed by shorter monitoring periods. This extended duration provides a more complete and clinically actionable picture of a patient's cardiac rhythm.

Pricing & Value

Cardiologs Holter Platform

Tool B offers greater transparency in its pricing model with a clear 'pay per ECG regardless the number of users' structure, allowing healthcare providers to better understand and budget for costs based on their usage volume. Tool A's pricing remains opaque, requiring direct vendor contact, which makes it harder to assess its value proposition without further engagement.

Enterprise Readiness

Cardiologs Holter Platform

Tool B demonstrates superior enterprise readiness by explicitly detailing EMR integration capabilities (Philips IntelliBridge Enterprise) and robust security certifications (ISO/IEC 27001 on AWS servers). While Tool A is HIPAA compliant and cloud-based, Tool B provides more concrete evidence of its ability to integrate seamlessly and securely within complex healthcare IT environments.

Innovation

ZEUS System (Zio Watch)

Tool A takes the lead in innovation by offering a novel wearable biosensor (Zio Watch) for long-term continuous cardiac monitoring, fundamentally changing how patients are monitored for extended periods. This approach, combined with AI analysis, represents a significant step forward from traditional, shorter-duration Holter monitoring.

Support & Docs

Tie

Both tools' descriptions lack explicit details on dedicated technical support channels or comprehensive documentation specifically for healthcare professionals. While Tool A mentions patient-facing educational content and provider apps for management, and Tool B highlights easy-to-read reports, neither provides enough information to definitively distinguish their professional support and documentation offerings.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature ZEUS System (Zio Watch) Cardiologs Holter Platform
Name ZEUS System (Zio Watch) Cardiologs Holter Platform
Company iRhythm Technologies Philips France Commercial
Core Technology AI-powered algorithm (ZEUS System) for advanced arrhythmia detection and analysis AI-powered deep learning technology for ECG analysis
Monitoring Approach Long-term continuous cardiac monitoring for up to 14 days via wearable biosensor (Zio Watch) Holter ECG analysis
Arrhythmia Detection Scope Detects and characterizes Atrial Fibrillation (AFib) and other cardiac arrhythmias; detects and characterizes Atrial Fibrillation (AFib) burden Detects over 20 types of arrhythmias
Key Differentiator Wearable biosensor (Zio Watch) for continuous ECG and PPG data collection Vendor-neutral compatibility with multiple Holter devices; reduces Holter analysis time by approximately 42%

Videos

Demos, reviews, and walkthroughs featuring ZEUS System (Zio Watch) and Cardiologs Holter Platform.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Tool A, the ZEUS System (Zio Watch), utilizes a proprietary wearable biosensor (Zio Watch) to collect continuous ECG and PPG data for long-term monitoring, up to 14 days. Tool B, the Cardiologs Holter Platform, is a cloud-based solution designed to analyze ECG data from various vendor-neutral Holter devices.
The ZEUS System (Tool A) is specifically designed to detect and characterize Atrial Fibrillation (AFib) burden and other cardiac arrhythmias. The Cardiologs Holter Platform (Tool B) is capable of detecting over 20 types of arrhythmias.
Tool A provides clinically actionable reports with 99% physician agreement, accessible via the ZioSuite portal and a provider mobile app. Tool B generates easy-to-read, automatically enriched reports and claims to reduce Holter analysis time by approximately 42%, with EMR integration capabilities.
Tool A includes the MyZio patient app, which allows for digital symptom logging, educational content, and reminders for patients. Tool B's description does not explicitly mention a patient-facing application or direct patient engagement features.
The ZEUS System (Tool A) is applicable across Cardiology, Family Medicine, and Internal Medicine. The Cardiologs Holter Platform (Tool B) is specifically designed for Cardiology specialists.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.